ExodusPoint Capital Management’s LeMaitre Vascular LMAT Stock Holding History

ExodusPoint Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-62,290	Closed	-$5.05M	–	1857
2025 Q4	$5.05M	Buy	62,290 +30,147	+94%	+$2.6M	0.04%	466
2025 Q3	$2.81M	Buy	32,143 +13,842	+76%	+$1.24M	0.03%	612
2025 Q2	$1.52M	Buy	+18,301	New	+$1.53M	0.01%	838
2023 Q3	–	Sell	-5,730	Closed	-$386K	–	1941
2023 Q2	$386K	Buy	+5,730	New	+$350K	﹤0.01%	1448
2022 Q2	–	Sell	-5,672	Closed	-$264K	–	2217
2022 Q1	$264K	Buy	+5,672	New	+$254K	﹤0.01%	1810
2021 Q4	–	Sell	-9,908	Closed	-$526K	–	2414
2021 Q3	$526K	Buy	9,908 +6,579	+198%	+$371K	0.01%	1346
2021 Q2	$203K	Buy	+3,329	New	+$177K	﹤0.01%	1975

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

ExodusPoint Capital Management's LMAT Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of LeMaitre Vascular (LMAT) in Q1 2026, closing a stake of 62,290 shares — an estimated $5.05M sold.

ExodusPoint Capital Management first reported a position in LMAT in Q2 2021 and held it in 7 quarters. The position peaked at $5.05M in Q4 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

ExodusPoint Capital Management reported no remaining LeMaitre Vascular position as of Q1 2026 after selling out during the quarter.
ExodusPoint Capital Management sold 62,290 LeMaitre Vascular shares in Q1 2026, an estimated $5.05M.
ExodusPoint Capital Management first reported a position in LeMaitre Vascular in Q2 2021 and held it in 7 quarters.
ExodusPoint Capital Management's LeMaitre Vascular position peaked at $5.05M in Q4 2025.
339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.